United Drug makes double acquisition
United Drug, a provider of services to healthcare manufacturers and pharmaceutical retailers, has agreed to acquire the entire issued share capital of Synopia, which provides market access services to pharmaceutical and biotech manufacturers in the US market.
United Drug, a provider of services to healthcare manufacturers and pharmaceutical retailers, has agreed to acquire the entire issued share capital of Synopia, which provides market access services to pharmaceutical and biotech manufacturers in the US market.
The purchase, which will be made for a total consideration of up to $12m, is being made to enable to the firm to broaden its range of services to clients in its Sales, Marketing & Medical division.
$3.2m of the consideration is payable in cash on completion, with an additional amount of up to $8.8m payable after three years on achievement of agreed profit targets.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
United Drug also announced plans to acquire the entire issued share capital of Drug Safety Alliance for a total consideration of up to $28m. The firm, which employs 94 people, provides safety and risk management services supporting pharmaceutical, biotech, medical device, animal and consumer health organisations.
The business will also form part of United's Sales, Marketing & Medical division and is being purchased to allow United to offer clients an integrated call centre and case processing pharmacovigilance service.
$21m of the consideration is payable in cash on completion with an additional amount of up to $7m payable after three years based on achievement of agreed profit targets.
Both acquisitions will be financed from United Drug's internal resources and existing debt facilities and is expected to be immediately accretive to earnings.
NR
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
Reeves warned against property tax shake-up – 3 ways it could backfire on first-time buyers
Rachel Reeves reportedly has her eye on high-end property taxes in the upcoming Budget, but there are concerns a shake-up could unintentionally hamper those trying to get on the housing ladder
-
Average Brits want to retire five years before they can – who has the widest retirement gap?
Brits are expecting to work for longer than ever but there are big disparities in the number of extra working years predicted. A small tweak could help close the gap